CA II, the gene in the sixth frontier, has been reported to be expressed in the neovessel endothelium and the tumor cell cytoplasm of medulloblastomas and primitive neuroectodermal tumors 41 and has been proposed as a biomarker gene for gastrointestinal stromal tumors 42. The gene discussed is CA2; the disease is primitive neuroectodermal tumor.